[Strategies of vaccination for adult population in Spain in the actuality].
Identifieur interne : 000589 ( Main/Exploration ); précédent : 000588; suivant : 000590[Strategies of vaccination for adult population in Spain in the actuality].
Auteurs : Angel Gil De MiguelSource :
- Anales de la Real Academia Nacional de Medicina [ 0034-0634 ] ; 2006.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Anatoxine tétanique (administration et posologie), Enfant (MeSH), Espagne (MeSH), Facteurs de risque (MeSH), Facteurs âges (MeSH), Femelle (MeSH), Grossesse (MeSH), Humains (MeSH), Mâle (MeSH), Rappel de vaccin (MeSH), Sujet immunodéprimé (MeSH), Sujet âgé (MeSH), Vaccin contre la rougeole, les oreillons et la rubéole (administration et posologie), Vaccination (tendances), Vaccins anti-hépatite A (administration et posologie), Vaccins anti-hépatite B (administration et posologie), Vaccins antigrippaux (administration et posologie), Vaccins antipneumococciques (administration et posologie).
- MESH :
- administration et posologie : Anatoxine tétanique, Vaccin contre la rougeole, les oreillons et la rubéole, Vaccins anti-hépatite A, Vaccins anti-hépatite B, Vaccins antigrippaux, Vaccins antipneumococciques.
- tendances : Vaccination.
- Adolescent, Adulte, Adulte d'âge moyen, Enfant, Espagne, Facteurs de risque, Facteurs âges, Femelle, Grossesse, Humains, Mâle, Rappel de vaccin, Sujet immunodéprimé, Sujet âgé.
- Wicri :
- geographic : Espagne.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Age Factors (MeSH), Aged (MeSH), Child (MeSH), Female (MeSH), Hepatitis A Vaccines (administration & dosage), Hepatitis B Vaccines (administration & dosage), Humans (MeSH), Immunization, Secondary (MeSH), Immunocompromised Host (MeSH), Influenza Vaccines (administration & dosage), Male (MeSH), Measles-Mumps-Rubella Vaccine (administration & dosage), Middle Aged (MeSH), Pneumococcal Vaccines (administration & dosage), Pregnancy (MeSH), Risk Factors (MeSH), Spain (MeSH), Tetanus Toxoid (administration & dosage), Vaccination (trends).
- MESH :
- chemical , administration & dosage : Hepatitis A Vaccines, Hepatitis B Vaccines, Influenza Vaccines, Measles-Mumps-Rubella Vaccine, Pneumococcal Vaccines, Tetanus Toxoid.
- geographic : Spain.
- trends : Vaccination.
- Adolescent, Adult, Age Factors, Aged, Child, Female, Humans, Immunization, Secondary, Immunocompromised Host, Male, Middle Aged, Pregnancy, Risk Factors.
Abstract
The introduction of vaccines around the world has avoided millions of deaths among children and adults every year. Taking into account that some vaccines administered in the childhood do not lend long term immunity, unless a booster dose is given, vaccinated subjects return susceptible with the course of time. Implementation of vaccination policies and recommendations to adult population is important in order to complement vaccination childhood programs and intensify its impact in the infection control.
PubMed: 17172219
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Strategies of vaccination for adult population in Spain in the actuality].</title><author><name sortKey="De Miguel, Angel Gil" sort="De Miguel, Angel Gil" uniqKey="De Miguel A" first="Angel Gil" last="De Miguel">Angel Gil De Miguel</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2006">2006</date><idno type="RBID">pubmed:17172219</idno><idno type="pmid">17172219</idno><idno type="wicri:Area/Main/Corpus">00577</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00577</idno><idno type="wicri:Area/Main/Curation">000577</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000577</idno><idno type="wicri:Area/Main/Exploration">000577</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Strategies of vaccination for adult population in Spain in the actuality].</title><author><name sortKey="De Miguel, Angel Gil" sort="De Miguel, Angel Gil" uniqKey="De Miguel A" first="Angel Gil" last="De Miguel">Angel Gil De Miguel</name></author></analytic><series><title level="j">Anales de la Real Academia Nacional de Medicina</title><idno type="ISSN">0034-0634</idno><imprint><date when="2006" type="published">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Age Factors (MeSH)</term><term>Aged (MeSH)</term><term>Child (MeSH)</term><term>Female (MeSH)</term><term>Hepatitis A Vaccines (administration & dosage)</term><term>Hepatitis B Vaccines (administration & dosage)</term><term>Humans (MeSH)</term><term>Immunization, Secondary (MeSH)</term><term>Immunocompromised Host (MeSH)</term><term>Influenza Vaccines (administration & dosage)</term><term>Male (MeSH)</term><term>Measles-Mumps-Rubella Vaccine (administration & dosage)</term><term>Middle Aged (MeSH)</term><term>Pneumococcal Vaccines (administration & dosage)</term><term>Pregnancy (MeSH)</term><term>Risk Factors (MeSH)</term><term>Spain (MeSH)</term><term>Tetanus Toxoid (administration & dosage)</term><term>Vaccination (trends)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Anatoxine tétanique (administration et posologie)</term><term>Enfant (MeSH)</term><term>Espagne (MeSH)</term><term>Facteurs de risque (MeSH)</term><term>Facteurs âges (MeSH)</term><term>Femelle (MeSH)</term><term>Grossesse (MeSH)</term><term>Humains (MeSH)</term><term>Mâle (MeSH)</term><term>Rappel de vaccin (MeSH)</term><term>Sujet immunodéprimé (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Vaccin contre la rougeole, les oreillons et la rubéole (administration et posologie)</term><term>Vaccination (tendances)</term><term>Vaccins anti-hépatite A (administration et posologie)</term><term>Vaccins anti-hépatite B (administration et posologie)</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Vaccins antipneumococciques (administration et posologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Hepatitis A Vaccines</term><term>Hepatitis B Vaccines</term><term>Influenza Vaccines</term><term>Measles-Mumps-Rubella Vaccine</term><term>Pneumococcal Vaccines</term><term>Tetanus Toxoid</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Spain</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Anatoxine tétanique</term><term>Vaccin contre la rougeole, les oreillons et la rubéole</term><term>Vaccins anti-hépatite A</term><term>Vaccins anti-hépatite B</term><term>Vaccins antigrippaux</term><term>Vaccins antipneumococciques</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Vaccination</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Age Factors</term><term>Aged</term><term>Child</term><term>Female</term><term>Humans</term><term>Immunization, Secondary</term><term>Immunocompromised Host</term><term>Male</term><term>Middle Aged</term><term>Pregnancy</term><term>Risk Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Enfant</term><term>Espagne</term><term>Facteurs de risque</term><term>Facteurs âges</term><term>Femelle</term><term>Grossesse</term><term>Humains</term><term>Mâle</term><term>Rappel de vaccin</term><term>Sujet immunodéprimé</term><term>Sujet âgé</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The introduction of vaccines around the world has avoided millions of deaths among children and adults every year. Taking into account that some vaccines administered in the childhood do not lend long term immunity, unless a booster dose is given, vaccinated subjects return susceptible with the course of time. Implementation of vaccination policies and recommendations to adult population is important in order to complement vaccination childhood programs and intensify its impact in the infection control.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17172219</PMID><DateCompleted><Year>2007</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2006</Year><Month>12</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0034-0634</ISSN><JournalIssue CitedMedium="Print"><Volume>123</Volume><Issue>1</Issue><PubDate><Year>2006</Year></PubDate></JournalIssue><Title>Anales de la Real Academia Nacional de Medicina</Title><ISOAbbreviation>An R Acad Nac Med (Madr)</ISOAbbreviation></Journal><ArticleTitle>[Strategies of vaccination for adult population in Spain in the actuality].</ArticleTitle><Pagination><MedlinePgn>175-94</MedlinePgn></Pagination><Abstract><AbstractText>The introduction of vaccines around the world has avoided millions of deaths among children and adults every year. Taking into account that some vaccines administered in the childhood do not lend long term immunity, unless a booster dose is given, vaccinated subjects return susceptible with the course of time. Implementation of vaccination policies and recommendations to adult population is important in order to complement vaccination childhood programs and intensify its impact in the infection control.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Miguel</LastName><ForeName>Angel Gil</ForeName><Initials>AG</Initials></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Estrategias de vacunación en la población adulta española en la actualidad.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>An R Acad Nac Med (Madr)</MedlineTA><NlmUniqueID>7505188</NlmUniqueID><ISSNLinking>0034-0634</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022362">Hepatitis A Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017325">Hepatitis B Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022542">Measles-Mumps-Rubella Vaccine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022242">Pneumococcal Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013745">Tetanus Toxoid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022362" MajorTopicYN="N">Hepatitis A Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017325" MajorTopicYN="N">Hepatitis B Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007117" MajorTopicYN="N">Immunization, Secondary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016867" MajorTopicYN="N">Immunocompromised Host</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022542" MajorTopicYN="N">Measles-Mumps-Rubella Vaccine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022242" MajorTopicYN="N">Pneumococcal Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013745" MajorTopicYN="N">Tetanus Toxoid</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>12</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>1</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>12</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17172219</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="De Miguel, Angel Gil" sort="De Miguel, Angel Gil" uniqKey="De Miguel A" first="Angel Gil" last="De Miguel">Angel Gil De Miguel</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000589 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000589 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:17172219
|texte= [Strategies of vaccination for adult population in Spain in the actuality].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:17172219" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |